Gregory E. Roland

543 total citations
11 papers, 460 citations indexed

About

Gregory E. Roland is a scholar working on Pharmacology, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Gregory E. Roland has authored 11 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Molecular Medicine. Recurrent topics in Gregory E. Roland's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Gregory E. Roland is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Gregory E. Roland collaborates with scholars based in United States. Gregory E. Roland's co-authors include Jing Li, Richard J. Heath, Charles O. Rock, Michael Cohen, Michael D. Huband, John M. Domagala, Mark J. Suto, Carl L. Heifetz, J. M. DOMAGALA and Martin A. Shapiro and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Gregory E. Roland

10 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory E. Roland United States 9 186 183 135 119 114 11 460
Terrance Moore United States 7 332 1.8× 197 1.1× 75 0.6× 115 1.0× 143 1.3× 8 597
Martin S. Linsell United States 11 166 0.9× 254 1.4× 193 1.4× 218 1.8× 136 1.2× 11 594
W. TOSCH Switzerland 10 74 0.4× 274 1.5× 165 1.2× 237 2.0× 117 1.0× 17 669
Rebecca Weiser United Kingdom 12 66 0.4× 193 1.1× 81 0.6× 95 0.8× 92 0.8× 24 454
Sara López Spain 13 181 1.0× 190 1.0× 156 1.2× 256 2.2× 67 0.6× 21 579
Sarah Paulin Switzerland 10 94 0.5× 212 1.2× 99 0.7× 221 1.9× 94 0.8× 11 632
Roberta J. Melander United States 16 174 0.9× 345 1.9× 91 0.7× 201 1.7× 144 1.3× 36 757
Steven M. Kwasny United States 10 144 0.8× 330 1.8× 120 0.9× 312 2.6× 98 0.9× 17 685
Masaya Takei Japan 15 145 0.8× 346 1.9× 264 2.0× 246 2.1× 117 1.0× 22 772
Diixa Patel United States 7 90 0.5× 209 1.1× 81 0.6× 209 1.8× 179 1.6× 7 435

Countries citing papers authored by Gregory E. Roland

Since Specialization
Citations

This map shows the geographic impact of Gregory E. Roland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory E. Roland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory E. Roland more than expected).

Fields of papers citing papers by Gregory E. Roland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory E. Roland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory E. Roland. The network helps show where Gregory E. Roland may publish in the future.

Co-authorship network of co-authors of Gregory E. Roland

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory E. Roland. A scholar is included among the top collaborators of Gregory E. Roland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory E. Roland. Gregory E. Roland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Heath, Richard J., Jing Li, Gregory E. Roland, & Charles O. Rock. (2000). Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and Hexachlorophene. Journal of Biological Chemistry. 275(7). 4654–4659. 201 indexed citations
2.
Renau, Thomas E., Gregory E. Roland, Martin A. Shapiro, et al.. (1996). Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Antimicrobial Agents and Chemotherapy. 40(10). 2363–2368. 42 indexed citations
3.
Cohen, Michael, et al.. (1995). In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci. Antimicrobial Agents and Chemotherapy. 39(9). 2123–2127. 26 indexed citations
4.
Cohen, Michael, et al.. (1994). In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and β-lactamase stability. Diagnostic Microbiology and Infectious Disease. 18(1). 31–39. 17 indexed citations
5.
Cohen, Michael, et al.. (1994). In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models. Diagnostic Microbiology and Infectious Disease. 18(1). 41–47. 1 indexed citations
6.
Huband, Michael D., et al.. (1993). In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency. Antimicrobial Agents and Chemotherapy. 37(12). 2563–2570. 8 indexed citations
7.
Suto, Mark J., et al.. (1992). Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity and antimicrobial activity. Journal of Medicinal Chemistry. 35(25). 4745–4750. 84 indexed citations
8.
Cohen, Michael, et al.. (1991). In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagnostic Microbiology and Infectious Disease. 14(3). 245–258. 29 indexed citations
9.
Cohen, Michael, et al.. (1991). In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). Diagnostic Microbiology and Infectious Disease. 14(5). 403–415. 12 indexed citations
10.
Cohen, Michael, et al.. (1991). In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent. Antimicrobial Agents and Chemotherapy. 35(1). 141–146. 28 indexed citations
11.
Brown, Carolyn & Gregory E. Roland. (1984). Characterization of exotoxin produced by a shellfish‐pathogenic Vibrio sp.. Journal of Fish Diseases. 7(2). 117–126. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terrance Moore Breakdown of academic impact, for papers by Martin S. Linsell Breakdown of academic impact, for papers by W. TOSCH Breakdown of academic impact, for papers by Rebecca Weiser Breakdown of academic impact, for papers by Sara López Breakdown of academic impact, for papers by Sarah Paulin Breakdown of academic impact, for papers by Roberta J. Melander Breakdown of academic impact, for papers by Steven M. Kwasny Breakdown of academic impact, for papers by Masaya Takei Breakdown of academic impact, for papers by Diixa Patel
Rankless by CCL
2026